Federation des caisses Desjardins du Quebec’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$1 | – | 2776 |
|
|
2025
Q1 | $1 | Sell |
3
-1
| -25% | -$10 | ﹤0.01% | 2657 |
|
|
2024
Q4 | $82 | Hold |
4
| – | – | ﹤0.01% | 2492 |
|
|
2024
Q3 | $117 | Hold |
4
| – | – | ﹤0.01% | 2485 |
|
|
2024
Q2 | $179 | Hold |
4
| – | – | ﹤0.01% | 2338 |
|
|
2024
Q1 | $436 | Hold |
4
| – | – | ﹤0.01% | 2251 |
|
|
2023
Q4 | $567 | Hold |
4
| – | – | ﹤0.01% | 2191 |
|
|
2023
Q3 | $873 | Hold |
4
| – | – | ﹤0.01% | 2163 |
|
|
2023
Q2 | $1.84K | Hold |
4
| – | – | ﹤0.01% | 2066 |
|
|
2023
Q1 | $2.72K | Hold |
4
| – | – | ﹤0.01% | 2037 |
|
|
2022
Q4 | $1.05K | Hold |
4
| – | – | ﹤0.01% | 2276 |
|
|
2022
Q3 | $1.77K | Hold |
4
| – | – | ﹤0.01% | 2285 |
|
|
2022
Q2 | $2K | Hold |
4
| – | – | ﹤0.01% | 2303 |
|
|
2022
Q1 | $4.51K | Hold |
4
| – | – | ﹤0.01% | 2224 |
|
|
2021
Q4 | $3.99K | Hold |
4
| – | – | ﹤0.01% | 2250 |
|
|
2021
Q3 | $5.36K | Hold |
4
| – | – | ﹤0.01% | 2220 |
|
|
2021
Q2 | $6.93K | Hold |
4
| – | – | ﹤0.01% | 2155 |
|
|
2021
Q1 | $6.44K | Hold |
4
| – | – | ﹤0.01% | 2123 |
|
|
2020
Q4 | $7.67K | Buy |
+4
| New | +$10.4K | ﹤0.01% | 1964 |
|
Other funds holding HEPA
Federation des caisses Desjardins du Quebec's HEPA Position: Q2 2025 in Review
Federation des caisses Desjardins du Quebec sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 3 shares — an estimated $1 sold.
Federation des caisses Desjardins du Quebec first reported a position in HEPA in Q4 2020 and held it in 18 quarters. The position peaked at $7.67K in Q4 2020. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.
- Federation des caisses Desjardins du Quebec reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 3 Hepion Pharmaceuticals shares in Q2 2025, an estimated $1.
- Federation des caisses Desjardins du Quebec first reported a position in Hepion Pharmaceuticals in Q4 2020 and held it in 18 quarters.
- Federation des caisses Desjardins du Quebec's Hepion Pharmaceuticals position peaked at $7.67K in Q4 2020.
- 4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2025, filed 14 Aug 2025.